Gemtuzumab and hypotension Patient Reports February 13, 2012

Gemtuzumab Side Effects Report #4596052-9
Gemtuzumab side effect was reported by a Consumer or non-health professional from on Dec 15, 2004. Female patient, 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: exanthem, hypotension, pyrexia. Gemtuzumab dosage: 10 MG 1X PER 1 DAY INTRAVENOUS. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, DIFLUCAN, MARCUMAR, VALTREX, VORICONAZOLE. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4938529-X
Gemtuzumab side effect was reported by a Consumer or non-health professional from ITALY on Feb 23, 2006. Female patient, 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: agitation, confusional state, headache , hypotension, infusion related reaction, vomiting. Gemtuzumab dosage: unknown. Patient recovered.

Gemtuzumab Side Effects Report #4906949-5
Gemtuzumab side effect was reported by a Consumer or non-health professional from ITALY on Jan 26, 2006. Female patient, 66 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: anuria, atelectasis, hypotension, intestinal ischaemia, pleural effusion, septic shock. Gemtuzumab dosage: 9 MG 1X PER 1 DAY. During the same period patient was treated with MEROPENEM, AMIKACIN, TEICOPLANIN. Patient died.

Gemtuzumab Side Effects Report #4928868-0
Gemtuzumab side effect was reported by a Consumer or non-health professional from ITALY on Feb 15, 2006. Female patient, 66 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: abdominal pain , anuria, atelectasis, hypotension, intestinal ischaemia, neutropenia, pleural effusion, septic shock. Gemtuzumab dosage: 9 MG 1X PER 1 DAY. During the same period patient was treated with MEROPENEM, AMIKACIN, TEICOPLANIN. Patient died.


Gemtuzumab Side Effects Report #4867737-1
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 01, 2005. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: hypotension, pyrexia. Gemtuzumab dosage: unknown. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4843539-7
Gemtuzumab side effect was reported by a Physician from UNITED STATES on Jan 12, 1998. Female patient, 64 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: febrile neutropenia, hypotension. Gemtuzumab dosage: A SINGLE 9 MG/M^2 DOSE, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4853930-0
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 03, 2005. Female patient, 64 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: chills, febrile neutropenia, hypotension. Gemtuzumab dosage: A SINGLE 9 MG/M^2 DOSE, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4823375-8
Gemtuzumab side effect was reported by a Consumer or non-health professional from PORTUGAL on Oct 27, 2005. Female patient, 62 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bradycardia, hypersensitivity, hypotension, hypoxia, somnolence. Gemtuzumab dosage: 10 MG 1X PER 1 DAY,. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, ACYCLOVIR, FLUCONAZOLE. Patient recovered.

Gemtuzumab Side Effects Report #4876486-5
Gemtuzumab side effect was reported by a Consumer or non-health professional from PORTUGAL on July 09, 1943. Female patient, 62 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bradycardia, hypersensitivity, hypotension, hypoxia, somnolence. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, ACYCLOVIR, FLUCONAZOLE. Patient recovered.


Gemtuzumab Side Effects Report #4653007-3
Gemtuzumab side effect was reported by a Pharmacist from on May 02, 2005. Male patient, 58 years of age, was diagnosed with acute myeloid leukaemia, neoplasm malignant and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: hepatic failure, hypotension, renal failure, venoocclusive liver disease. Gemtuzumab dosage: 17MG IV (9MG/M2). Patient died on 02/15/2005.

Gemtuzumab Side Effects Report #4867042-3
Gemtuzumab side effect was reported by a Health Professional from NETHERLANDS on Mar 10, 2002. Male patient, 53 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: asthenia, blast cells present, blood lactate dehydrogenase increased, hypertension, hypotension, infection , pancytopenia, pneumonia , respiratory failure. Gemtuzumab dosage: CYCLE 1 (13-OCT-98) : CYCLE 2 CYCLE INTRAVENOUS; 2 (02-NOV-98) : 9 MG/M (2). During the same period patient was treated with CIPROXIN, DIFLUCAN, TAVEGIL. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #4724997-5
Gemtuzumab side effect was reported by a Pharmacist from UNITED STATES on July 22, 2005. Female patient, 37 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: haematochezia, hypotension, infusion related reaction. Gemtuzumab dosage: unknown. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #6057696-0
Gemtuzumab side effect was reported by a Physician from SPAIN on Jan 27, 2009. Male patient, 35 years of age, weighting 174.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: ascites, bacteraemia, haematotoxicity, hepatotoxicity, hyperbilirubinaemia, hypotension, hypovolaemic shock, ischaemic hepatitis, neutropenic colitis. Gemtuzumab dosage: unknown. During the same period patient was treated with CYTARABINE, IDARUBICIN. Patient was hospitalized and became disabled. Patient recovered.

Gemtuzumab Side Effects Report #5270170-4
Gemtuzumab side effect was reported by a Physician from ITALY on Mar 15, 2007. Female patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: hypotension, septic shock. Gemtuzumab dosage: unknown. During the same period patient was treated with AMIKACIN, TEICOPLANIN, MEROPENEM. Patient died on 01/25/2006.


Gemtuzumab Side Effects Report #5270232-1
Gemtuzumab side effect was reported by a Physician from PORTUGAL on Mar 15, 2007. Female patient, weighting 178.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bradycardia, hypersensitivity, hypotension, hypoxia, somnolence. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, FLUCONAZOLE, ACYCLOVIR. Patient recovered.

Gemtuzumab Side Effects Report #6087782-0
Gemtuzumab side effect was reported by a Physician from ITALY on Feb 19, 2009. Male patient, weighting 159.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: hypotension, hypoxia. Gemtuzumab dosage: unknown. During the same period patient was treated with VANCOMYCIN, CASPOFUNGIN ACETATE, MEROPENEM. Patient died on 02/16/2009.

Gemtuzumab Side Effects Report #4700276-7
Gemtuzumab side effect was reported by a Physician from on June 24, 2005. Female patient, weighting 180.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: brain oedema, confusional state, ecchymosis, hypertension, hypotension, oxygen consumption increased, petechiae, purpura, pyrexia. Gemtuzumab dosage: 3 MG/M2 /DOSE IV. During the same period patient was treated with VANCOMYCIN, CYTARABINE, DAUNORUBICIN, ETOPOSIDE, DEXAMETHASONE EYE DROPS, CEFTRIAXONE, CEFTAZIDIME. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4631147-2
Gemtuzumab side effect was reported by a Pharmacist from on Apr 07, 2005. Male patient, child 10 years of age, weighting 143.3 lb, was diagnosed with acute lymphocytic leukaemia, leukaemia recurrent and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: ascites, fluid overload, hyperbilirubinaemia, hypotension, sepsis , transaminases increased, venoocclusive liver disease. Gemtuzumab dosage: 7.8 MG X 1 DOSE INTRAVENOU. During the same period patient was treated with ALEMTUZUMAB, MEROPENEM, VANCOMYCIN, METHYLPREDNISOLONE, PENTAMIDINE, AMBISOME, PROZAC. Patient recovered.

Gemtuzumab Side Effects Report #5014006-5
Gemtuzumab side effect was reported by a Consumer or non-health professional from ITALY on May 17, 2006. Female patient, 71 years of age, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: agitation, confusional state, headache , hypersensitivity, hypotension, infusion related reaction, vomiting. Gemtuzumab dosage: 10 MG 1X PER 1 DAY. Patient recovered.